PRCT - PROCEPT BioRobotics Corp


24.22
-1.130   -4.666%

Share volume: 2,413,315
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$25.35
-1.13
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
39%
Profitability 35%
Dept financing 30%
Liquidity 75%
Performance 36%
Company vs Stock growth
vs
Performance
5 Days
-6.49%
1 Month
-17.08%
3 Months
-28.83%
6 Months
-37.77%
1 Year
-59.18%
2 Year
-50.85%
Key data
Stock price
$24.22
P/E Ratio 
0.00
DAY RANGE
$22.77 - $24.71
EPS 
-$1.71
52 WEEK RANGE
$19.35 - $66.85
52 WEEK CHANGE
-$57.94
MARKET CAP 
1.758 B
YIELD 
N/A
SHARES OUTSTANDING 
56.390 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
0.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,604,776
AVERAGE 30 VOLUME 
$2,182,956
Company detail
CEO: Reza Zadno
Region: US
Website: procept-biorobotics.com
Employees: 430
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery.

Recent news